Amarin Corp Plc (AMRN)

[iwishiknew]

Kiwi
All branded (and probably generic) drug pricing (including V) is probably best understood as a game of 3 card Monte.

The following $ amounts are estimates for illustration only (don't get lost in the tress and miss the forrest).
V is "priced" at about $310/120 gm. [I think]
But AMRN only sees Net product revenue of about $110/120gm
(=> -COGS 22% => GM $86/120gm)

Where did the other $200 go? Well (for insured patients), Pharmacy + Distributor + PBM + contractual allowance (w Insurors) + Coupon rebate have split that bag o' money.

I'd guess that AMRN would have to decrease 'price' by $2-3 for insuror to see a savings of $1 - but don't really know how the middlemen adjust their charges (as they are eventually a cost to the insurors though appear to be a cost to AMRN and further complicated by PBMs-insurors-pharmacy vertically integrated ). Would love to hear from a health insurance pro, but it seems costs need to be wrung out from PBM and Distributors.

Wonder if AMRN could offer special coupon to patients with documented Marine indication that would undercut generic pricing??? Why would any (non-government covered) Marine patient choose a generic?